Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 25,016,458
- Estimated value
- Report date
- 26 Feb 2026
- Price
- Ownership
- By Flagship VentureLabs VI, LLC
Ph.D. Noubar B. Afeyan - Director, 10%+ Owner at Generate Biomedicines, Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- GENB on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Ph.D. Noubar B. Afeyan since 04 Aug 2025
Reported holdings for Ph.D. Noubar B. Afeyan in Generate Biomedicines, Inc.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 15,264,724
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VII, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 12,723,940
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VI, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 4,340,252
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By FPN II, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 2,777,752
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Special Opportunities Fund II, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 1,562,500
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Pioneering Medicines 02, LLC
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Common Stock
- Shares / value
- 987,491
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Nutritional Health LTP Fund, L.P.
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 29,561
- Estimated value
- Report date
- 26 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VII, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VI, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Nutritional Health LTP Fund, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VII, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VI, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Special Opportunities Fund II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By FPN II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Fund VII, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By Flagship Pioneering Special Opportunities Fund II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Generate Biomedicines, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- By FPN II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ph.D. Noubar B. Afeyan in Generate Biomedicines, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.